Potential Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in the Perioperative Period

被引：5

作者：

Hulst, Abraham H. ^{[1
]}

Hermanides, Jeroen ^{[1
]}

DeVries, J. Hans ^{[2
]}

Preckel, Benedikt ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, Amsterdam, Netherlands

[2] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol, Amsterdam, Netherlands

来源：

ANESTHESIA AND ANALGESIA | 2018年 / 127卷 / 01期

关键词：

HEART-FAILURE; MORTALITY;

D O I：

10.1213/ANE.0000000000003349

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：306 / 307

页数：2

共 6 条

[1] Impact of heart failure on patients undergoing major noncardiac surgery [J].

Hammill, Bradley G. ;

Curtis, Lesley H. ;

Bennett-Guerrero, Elliott ;

O'Connor, Christopher M. ;

Jollis, James G. ;

Schulman, Kevin A. ;

Hernandez, Adrian F. .

ANESTHESIOLOGY, 2008, 108 (04) :559-567

[2] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes [J].

Neal, Bruce ;

Perkovic, Vlado ;

Mahaffey, Kenneth W. ;

de Zeeuw, Dick ;

Fulcher, Greg ;

Erondu, Ngozi ;

Shaw, Wayne ;

Law, Gordon ;

Desai, Mehul ;

Matthews, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) :644-657

[3] Perioperative Considerations for the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes [J].

Peacock, Sharon C. ;

Lovshin, Julie A. ;

Cherney, David Z. I. .

ANESTHESIA AND ANALGESIA, 2018, 126 (02) :699-704

[4] Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation [J].

Uthman, Laween ;

Baartscheer, Antonius ;

Bleijlevens, Boris ;

Schumacher, Cees A. ;

Fiolet, Jan W. T. ;

Koeman, Anneke ;

Jancev, Milena ;

Hollmann, Markus W. ;

Weber, Nina C. ;

Coronel, Ruben ;

Zuurbier, Coert J. .

DIABETOLOGIA, 2018, 61 (03) :722-726

[5] Mortality and Readmission of Patients With Heart Failure, Atrial Fibrillation, or Coronary Artery Disease Undergoing Noncardiac Surgery An Analysis of 38 047 Patients [J].

van Diepen, Sean ;

Bakal, Jeffrey A. ;

McAlister, Finlay A. ;

Ezekowitz, Justin A. .

CIRCULATION, 2011, 124 (03) :289-U65

[6] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].

Zinman, Bernard ;

Wanner, Christoph ;

Lachin, John M. ;

Fitchett, David ;

Bluhmki, Erich ;

Hantel, Stefan ;

Mattheus, Michaela ;

Devins, Theresa ;

Johansen, Odd Erik ;

Woerle, Hans J. ;

Broedl, Uli C. ;

Inzucchi, Silvio E. ;

Aizenberg, D. ;

Ulla, M. ;

Waitman, J. ;

De Loredo, L. ;

Farias, J. ;

Fideleff, H. ;

Lagrutta, M. ;

Maldonado, N. ;

Colombo, H. ;

Ferre Pacora, F. ;

Wasserman, A. ;

Maffei, L. ;

Lehman, R. ;

Selvanayagam, J. ;

d'Emden, M. ;

Fasching, P. ;

Paulweber, B. ;

Toplak, H. ;

Luger, A. ;

Drexel, H. ;

Prager, R. ;

Schnack, C. ;

Schernthaner, G. ;

Fliesser-Goerzer, E. ;

Kaser, S. ;

Scheen, A. ;

Van Gaal, L. ;

Hollanders, G. ;

Kockaerts, Y. ;

Capiau, L. ;

Chachati, A. ;

Persu, A. ;

Hermans, M. ;

Vantroyen, D. ;

Vercammen, C. ;

Van de Borne, P. ;

Mathieu, C. ;

Benhalima, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) :2117-2128

← 1 →